Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03672747 · ClinicalTrials.gov registry record · NA
Modulation of Spontaneous Cortical Activity by tDCS: BRAIN Initiative I
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
NCT03672747 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 133 participants.
The verdict
NCT03672747, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
Study Summary
This study will determine whether transcranial direct current stimulation (tDCS) can be used alter the amplitude of spontaneous neural activity, and thereby modulate cognitive function in healthy adults
Interventions
- DEVICE transcranial direct-current stimulation (tDCS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2019-02-20 |
| Est. Completion | 2023-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03672747
The ClinicalTrials.gov registry entry for NCT03672747 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which transcranial direct-current stimulation (tDCS) is the first listed.
NCT03672747 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03672747 about?
NCT03672747 is a clinical study titled "Modulation of Spontaneous Cortical Activity by tDCS: BRAIN Initiative I". This study will determine whether transcranial direct current stimulation (tDCS) can be used alter the amplitude of spontaneous neural activity, and thereby modulate cognitive function in healthy adults
What is the current status of trial NCT03672747?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2019-02-20. Estimated completion is 2023-05-31.
What interventions are being tested in trial NCT03672747?
The interventions under investigation include: transcranial direct-current stimulation (tDCS) (DEVICE).
Who is sponsoring clinical trial NCT03672747?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.